Shi‐Ying Cai

3.7k citations
55 papers · 2.7k indexed · h-index 31
Topics
Drug Transport and Resistance Mechanisms (36 papers)Pediatric Hepatobiliary Diseases and Treatments (19 papers)Liver Disease Diagnosis and Treatment (14 papers)

In The Last Decade

Shi‐Ying Cai

55 papers receiving 2.7k citations

Peers

Shi‐Ying Cai
Comparison fields: 5 of 106
  • Oncology 1.4k
  • Molecular Biology 896
  • Epidemiology 865
  • Surgery 789
  • Hepatology 623
Replace Siegfried Matern with:
Siegfried Matern Germany
Bryan L. Copple United States
Jyrki J. Eloranta Switzerland
Carsten Gartung Germany
Mihwa Choi United States
Stan F.J. van de Graaf Netherlands
Carol J. Soroka United States
Andrea Fuchsbichler Austria
Tappei Takada Japan
Wei‐Dong Chen China
Shi‐Ying Cai relative to Siegfried Matern Germany Siegfried Matern's profile →
Citations per field
00.5×3.6×
Siegfried Matern · 1×
Citations per year

Countries citing papers authored by Shi‐Ying Cai

Since Specialization
Citations

This map shows the geographic impact of Shi‐Ying Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi‐Ying Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi‐Ying Cai more than expected).

Fields of papers citing papers by Shi‐Ying Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi‐Ying Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi‐Ying Cai. The network helps show where Shi‐Ying Cai may publish in the future.

Co-authorship network of co-authors of Shi‐Ying Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Shi‐Ying Cai. A scholar is included among the top collaborators of Shi‐Ying Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi‐Ying Cai. Shi‐Ying Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 28
3 8
4 6
5 50
6 38
7 80
8 35
9 37
10 49
11 30
12 72
13 74
14 73
15 61
16 81
17 41
18 241
19 138
20 9

About Shi‐Ying Cai

Shi‐Ying Cai is a scholar working on Hepatology, Oncology and Surgery, having authored 55 papers that have together received 2.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (36 papers), Pediatric Hepatobiliary Diseases and Treatments (19 papers) and Liver Disease Diagnosis and Treatment (14 papers). The work is most often cited by research in Hepatology (623 citations), Oncology (1.4k citations) and Pharmacology (381 citations). Shi‐Ying Cai has collaborated with scholars based in United States, China and Australia. Frequent co-authors include James L. Boyer, Carol J. Soroka, Albert Mennone, Man Li, Nazzareno Ballatori, Hongwei He, Thomas Welte, Jittima Weerachayaphorn, Tong Wu and Yingjian Wang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026